Active Filter(s):
Details:
Blexten (bilastine) is a second-generation antihistamine drug, exerts its effect through its highly selective inhibition of peripheral histamine H1 receptors for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria.
Lead Product(s): Bilastine
Therapeutic Area: Immunology Product Name: Blexten
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Miravo Healthcare
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 01, 2022